KARYOPHARM THERAPEUTICS INC

CUSIP: 48576U106 Class: Common Stock

Eversept Partners, LP's Holding History (CIK: 0001697013)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 2,088,757 Value ($000) $1,413 Avg Close — Range —
Q3 2024
Shares 5,547,880 Value ($000) $4,605 Avg Close — Range —
Q2 2024
Shares 4,987,180 Value ($000) $4,327 Avg Close — Range —
Q1 2024
Shares 5,016,320 Value ($000) $7,575 Avg Close — Range —